Etigam

Yes, several reports mention the abuse potential of Etigam 0.25 Tablet MD. Therefore, it should be used with caution in patients prone to drug abuse.

As compared to other benzodiazepines, Etigam 0.25 Tablet MD has lesser sedative effects, lower dependence, and lower tolerance. However, long-term use can reduce the effectiveness of the medicine and may cause dependence and addiction.

Stopping Etigam 0.25 Tablet MD suddenly may cause withdrawal symptoms, which may include anxiety, insomnia, headache, dizziness, ringing sound in the ear (tinnitus), eating disorder (anorexia), vomiting, nausea, tremors, weakness, excessive sweating (perspiration), irritability, hypersensitivity to visual and auditory stimuli. Stopping the medicine suddenly may also cause palpitations, a fast heart rate, and postural hypotension (drop in blood pressure on standing). In severe and rare cases of withdrawal from high doses, patients may develop seizures, mental disorders (psychosis), agitation, confusion, and hallucinations.

Yes, like other benzodiazepines, it causes muscle relaxation, but otherwise, it is mainly used for anxiety.

Like other benzodiazepines, it causes sleepiness but is mainly used for anxiety disorders. It increases total sleep time and decreases the proportion of rapid eye movement (REM) sleep, wherein your eyes move quickly in different directions. Etigam 0.25 Tablet MD does not affect sleep latency (the amount of time it takes you to go from being fully awake to being asleep).

No, Etigam 0.25 Tablet MD is not an antidepressant. It is used for the treatment of generalized anxiety disorder with depressive symptoms. However, it may affect the patient's mood.